Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Denis Chem Lab Ltd has informed BSE that its Board of Directors will meet on 13th November 2025 to consider and approve the Unaudited Financial Results for the quarter ended 30th September 2025 (Q2 FY26). The company manufactures parenteral (injectable) pharmaceutical products and is listed on BSE under code 537536. As per SEBI insider trading rules, the trading window for designated persons remains closed until 48 hours after the results are declared. No financial figures or business details have been disclosed in this filing — it is a standard advance notice required under SEBI LODR Regulations.
This is a routine regulatory intimation with no immediate impact on shareholders. Investors should watch for the actual Q2 results on 13th November 2025, which could influence the stock depending on the numbers reported.